SEC Comment Letter for Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343) (LCTX) — Feb 8, 2011

Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343)
Date: Feb. 8, 2011 · CIK: 0000876343 · Accession: 0000000000-11-008338

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

January 20, 2011

Author

Melissa Rocha

Form

UPLOAD

Company

Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343)

Letter

January 20, 2011 Dr. Michael D. West, PhD. Chief Executive Officer BioTime, Inc. 1301 Harbor Bay Parkway, Suite 100 Alameda, California 94502 Re: BioTime, Inc. 0B Form 10- K for the Fiscal Year E nded December 31, 2009 Definitive Proxy Statement Filed April 30, 2010 File No. 001 -12830

Dear D r. West :

We have completed our review of your Form10- K and related filings and have no further comments at this time.

Sincerely,
Melissa Rocha
Accounting Branch Chief

Show Raw Text

January  20, 2011
  Dr. Michael D. West, PhD.
Chief Executive Officer
BioTime, Inc.
1301 Harbor Bay Parkway, Suite 100
Alameda, California 94502
Re: BioTime, Inc.
0B Form 10- K for the Fiscal Year E nded December 31, 2009
Definitive Proxy Statement
Filed April 30, 2010
File No. 001 -12830

Dear D r. West :

We have completed our review of your Form10- K and related filings and have no further
comments at this time.

Sincerely,

Melissa Rocha
Accounting Branch Chief

SecProbe.io